Laura McNeillie picks up NICE award at Chief Allied Health Professions Officer’s awards
NICE has updated its guidance for the support of people living with dementia.
Evidence-based recommendations on laparoscopic ventral mesh rectopexy for internal rectal prolapse in adults
Evidence-based recommendations on unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor in adults
This guideline covers diagnosing and managing dementia (including Alzheimer’s disease). It aims to improve care by making recommendations on training staff and helping carers to support people living with dementia.
Evidence-based recommendations on donepezil (Aricept), galantamine (Reminyl), rivastigmine (Exelon) and memantine (Ebixa) for treating Alzheimer's disease
Deyo tells us how the NICE multimorbidity guideline is helping him to help his patients.
Women with a type of early breast cancer may not benefit from continuing or starting a drug after having surgery, NICE says in draft guidance.
Fiona invites us to join her at NICE’s social care data jam
Celia introduces the topic of clinical improvement and discusses how it affects changes in the NHS
Evidence-based recommendations on intranasal phototherapy to reduce inflammation inside the nose in allergic rhinitis in adults
Evidence-based recommendations on arsenic trioxide (Trisenox)for treating acute promyelocytic leukaemia (APML) in adults
Evidence-based recommendations on atezolizumab (Tecentriq) for previously treated locally advanced or metastatic urothelial carcinoma in adults
Evidence-based recommendations on on midostaurin (Rydapt) for untreated FLT3-mutation-positive acute myeloid leukaemia (AML) in adults
Evidence-based recommendations on guselkumab (Tremfya) for treating moderate to severe plaque psoriasis in adults
Evidence-based recommendations on brentuximab vedotin (Adcetris) for treating relapsed or refractory CD30-positive Hodgkin lymphoma in adults
People who have suffered trauma and are at risk of post-traumatic stress disorder (PTSD) should be offered therapy within one month, NICE says in new draft guidance.
David has been honoured in Her Majesty, the Queen’s birthday honours list to recognise his outstanding achievements in NHS Leadership.
NICE Scientific Advice (NSA) launched a new health economic model review service, PRIMA, in December 2017 and it is already proving to be a valuable resource for model developers.
NICE says more people should be able to freely access pembrolizumab, known as Keytruda, after a new trial shows it helps certain adults with lung cancer live more than a year longer.
This guideline covers assessing and managing cancers of the upper aerodigestive tract in people aged 16 and over. These are cancers of the airways of the head and neck, including the mouth, throat, larynx (voicebox) and sinuses. It aims to reduce variation in practice and improve survival.
Evidence-based recommendations on low-level laser therapy for preventing or treating oral mucositis caused by radiotherapy or chemotherapy
Evidence-based recommendations on endoscopic bipolar radiofrequency ablation (heat energy) to treat biliary obstruction (bile duct blockage) caused by cancer
Victoria Hilton and her team, finalists of the NICE Shared Learning Awards, tell us about an improved care pathway to support better outcomes for patients with gastrointestinal problems
Jason tells us why winning a prestigious Skills for Care award matters to him and his team
Evidence-based recommendations on atezolizumab (Tecentriq) for locally advanced or metastatic non-small-cell lung cancer (NSCLC) after chemotherapy in adults
Reductions to the price of three multiple sclerosis (MS) drugs mean NICE is now able to recommend them for routine NHS funding.
The Food First team, finalists of the NICE Shared Learning Awards, tell us about their approach to improving nutritional care in care homes
Evidence-based recommendations on percutaneous balloon valvuloplasty for fetal critical aortic stenosis
NICE has published new guidance to help healthcare professionals optimise the treatment of urinary tract infections (UTIs).
NICE has recommended three blood cancer drugs, brentuximab vedotin, midostaurin and arsenic trioxide be made available on the NHS.
NICE has published draft guidance in which dinutuximab beta is not recommended as a treatment for high-risk neuroblastoma – a rare type of cancer that mainly affects children and young people.
Sheela discusses why we should encourage more people from BAME backgrounds to apply for senior level roles and be involved in NICE committees.
NICE has announced that Meindert Boysen has been appointed as its director of the Centre for Health Technology Evaluation.
Men suffering with symptoms from an enlarged prostate could be offered a new type of nonsurgical treatment thanks to changes in NICE guidance.
Evidence-based recommendations on DYSIS colposcope with DYSISmap and ZedScan I for assessing suspected cervical abnormalities in people having colposcopy
Evidence-based recommendations on pembrolizumab (Keytruda) for locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy
Evidence-based recommendations on prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia in adults
Evidence-based recommendations on microinvasive subconjunctival insertion of a trans-scleral gelatin stent (tube) for primary open-angle glaucoma in adults
Evidence-based recommendations on robot-assisted kidney transplant in adults
Fiona explains how a new questionnaire could be used to increase healthy food and drink options in hospital retail outlets
Evidence-based recommendations on nerve transfer to partially restore upper limb function in people with tetraplegia (quadriplegia; paralysis of arms and legs)
This guideline covers recognising, assessing and treating mental health problems in women who are planning to have a baby, are pregnant, or have had a baby or been pregnant in the past year. It covers depression, anxiety disorders, eating disorders, drug- and alcohol-use disorders and severe mental illness (such as psychosis, bipolar disorder and schizophrenia). It promotes early detection and good management of mental health problems to improve women’s quality of life during pregnancy and in the year after giving birth.
This guideline covers identifying and managing depression in adults aged 18 years and older, in primary and secondary care. It aims to improve care for people with depression by promoting improved recognition and treatment.
This guideline covers recognising, assessing and treating bipolar disorder (formerly known as manic depression) in children, young people and adults. The recommendations apply to bipolar I, bipolar II, mixed affective and rapid cycling disorders. It aims to improve access to treatment and quality of life in people with bipolar disorder.
Professor Stansby, expert advisor on the VTE guideline, highlights a call for research launched by NICE and NIHR, into the risk assessment tools
Evidence-based recommendations on tocilizumab (RoActemra) for treating giant cell arteritis in adults
Sharon discusses NICE’s learning disabilities guideline and how organisations can work to improve local services
Thines tells us why NICE committees benefit from diverse representation.
NICE says people growing older with learning disabilities need to have annual health checks to help them manage conditions that can quickly affect them as they grow older.